Between 2010 and 2011, drugmakers trimmed their sales teams by 7 percent. But despite the huge number of sales reps being thrown overboard in recent years, select hiring does still occur. The obvious impetus is when a new drug is approved by the FDA. Of course, such hiring may not compensate for lost jobs, but several drugmakers last year did grow their sales forces, according to a new report from Cegedim Strategic Data.
